Manufacturing . net

Medical

Subscribe to Medical
View Sample

FREE Email Newsletter

Today in Manufacturing

Daily news and top headlines for manufacturing professionals

J&J Gets FDA Warning About Handling Of Complaints

May 31, 2012 9:18 am | News | Comments

The FDA says a J&J unit received 227 complaints about various products and most often closed them without a thorough investigation.

Senate Bill Aims To Increase Drug Import Safety

May 25, 2012 9:24 am | by Matthew Perrone, AP Health Writer | News | Comments

U.S. regulators would inspect more drug manufacturing facilities in China, India and other foreign countries in order to ensure quality.

Boston Scientific Gets Approval For New Leg Stent

May 18, 2012 9:09 am | News | Comments

Medical device maker Boston Scientific Corp. said it received U.S. approval for a new type of stent to treat blocked arteries in the legs.

Advertisement

Agilent Buying Dako For $2.2B

May 17, 2012 9:03 am | News | Comments

Agilent Technologies Inc. said it is buying the cancer diagnostic company to help it develop a wider range of cancer-fighting products.

Medtronic: Bone Graft Investigation Is Over

May 16, 2012 9:39 pm | News | Comments

Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft.

CryoLife Buying Vascular Graft Maker For $17M

May 15, 2012 9:50 pm | News | Comments

Medical device maker has agreed to buy Hemosphere Inc., which makes a vascular graft that is used in kidney dialysis patients, for $17 million in cash.

Alere Skids On Expected Recall, Federal Subpoena

May 11, 2012 2:23 pm | News | Comments

Shares of the medical diagnostics company slipped after it announced that the government was concerned over its marketing and quality-control testing.

Seven Success Criteria For Hiring A GMP Consultant

May 11, 2012 1:33 pm | by The QA Pharm | Blogs | Comments

There is nothing worse than throwing a bunch of consultants at a problem without knowing the boundaries of the project or defining the expected results. Unfortunately, it happens all the time. It ends in frustration for all parties involved. A formal scope of work (SOW) helps both the client and the consultant to set expectations of each other, and agree on basic assumptions that are critical to success.

Advertisement

Omnicare Pays $50 Million To Settle DOJ Case

May 11, 2012 12:52 pm | News | Comments

The company said there were no allegations that drugs were illegally diverted to someone without prescriptions and no patients were harmed.

Two Molecular Biologists Get $500K Medical Prize

May 11, 2012 9:29 am | News | Comments

The two men performed pioneering research on how cells express their genetic information at The Rockefeller University in New York City.

Company Recalls Nebraska Lethal Injection Drug

May 10, 2012 9:24 am | by Grant Schulte, Associated Press | News | Comments

Naari AG asked Nebraska officials to quarantine its supply of sodium thiopental because it was "illegally diverted" from its supply chain.

China To Reinvestigate Human Flesh Capsule Claims

May 8, 2012 9:18 am | News | Comments

South Korean officials say they seized smuggled capsules containing powdered remains of dead babies, which some believe can cure a variety of diseases.

Abbott Labs Settles $1.5B Dispute Over Drug Claims

May 7, 2012 1:03 pm | by Pete Yost, Associated Press | News | Comments

Attorneys general from across the country alleged that Abbott marketed its anti-seizure drug Depakote for unapproved uses.

Contract Manufacturing And Recalls

May 7, 2012 12:18 pm | by Mike Rozembajgier, Vice President of Recalls, StericycleExpertRECALL | Articles | Comments

Pharmaceutical companies face increased competition to meet consumer demand, which means tighter and more complex deals with contract manufacturers.

NIH, Companies Aim To Teach Old Drugs New Tricks

May 3, 2012 2:08 pm | by Lauran Neergaard, AP Medical Writer | News | Comments

Pfizer, AstraZeneca and Eli Lilly & Co. are dusting off two dozen old drugs that failed to treat one disease but might treat another.

Impax Labs Falls On Weak Sales, New FDA Warning

May 2, 2012 9:27 am | News | Comments

The FDA recently issued a Form 483, which said inspectors found problems in Impax's quality control laboratory.

US Approves Antibiotic To Treat, Prevent Plague

April 30, 2012 9:38 am | by the Associated Press | News | Comments

The Johnson & Johnson antibiotic is able to cure a vast majority of the rare bacterial infections, which could be use as a potential bioterrorism agent.

Hologic Buying Gen-Probe For About $3.72B

April 30, 2012 8:47 am | News | Comments

Medical device maker Hologic Inc. said Monday that it will buy diagnostic test maker Gen-Probe for about $3.72 billion in an all-cash deal.

Novo Nordisk To Expand U.S. Workforce By 15 Pct.

April 27, 2012 2:18 pm | News | Comments

The company will look to fill positions at its new type 1 diabetes research center in Seattle and at a manufacturing plant in North Carolina.

New J&J CEO Plans Realistic, Optimistic Future

April 26, 2012 9:23 am | by Linda A. Johnson, AP Business Writer | News | Comments

New CEO Alex Gorsky said one of his short-term priorities is to get "reliable" consumer products back on store shelves.

Alabama Restricts Cold Medicines To Stop Meth

April 20, 2012 2:00 pm | by Phillip Rawls, Associated Press | News | Comments

The bill is the latest in recent years to try to slow down meth production, which uses cold and allergy medicine containing ephedrine or pseudoephedrine.

Does Giving Antibiotics To Animals Hurt Humans?

April 20, 2012 1:45 pm | by Matthew Perrone, AP Health Writer | News | Comments

Antibiotics have saved countless lives in treating a variety of diseases, but some argue their use in meat breeds antibiotic-resistant germs.

Medical Firm To Build Plasma Plant In Georgia

April 19, 2012 9:35 am | by Errin Haines, Associated Press | News | Comments

Baxter International Inc. will employ about 1,500 people to make plasma-based therapies that treat chronic and life-threatening illnesses.

EU Clears J&J's $21.3BN Synthes Acquisition

April 19, 2012 8:31 am | News | Comments

The European Union's competition regulator says it has approved Johnson & Johnson's $21.3 billion acquisition of Swiss orthopedics maker Synthes.

High Court Weighs Overtime Pay For Drug Sales Reps

April 17, 2012 9:38 am | by Mark Sherman, Associated Press | News | Comments

The justices questioned whether the federal law governing overtime pay should apply to those who try to persuade doctors to prescribe certain drugs.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading